ISPOR Annual 2019: RTI-HS Presentations

The Inclusion of the Utility Values for Carers and Family Members in HTAs: a Case Study of Recent NICE Appraisals in the UK. 
Basarir H, Brockbank J, Knight C, Wolowacz S.

Explaining the Rotavirus Serotype-Distribution Shift in Children After Vaccinations Using a Simple Transmission Model
Gould IG, Herring W, Benninghoff B, Standaert B

A systematic review of ICER evaluations from 2008 to 2018: recent trends in evaluation process and lessons learned.
Ronquest NA, Gould IG, Barnett CL, Mladsi DM

 

Leveraging real-world evidence to address uncertainty for transformative and curative therapies. Moderator: Molly Purser
Special Interest Group Forum
Tuesday, May 21 12:30 pm

 

Sunday, May 19 - ISPOR Pre-conference Short Courses 

8:00-12:00 

 

Budget impact analysis I - a 6-step approach. Earnshaw S, Mauskopf J, Mullins D.

8:00-12:00 

 

Stated preference methods - part 1. Bridges JFP, Hauber AB, Marshall D. 

1:00-5:00 

 

Budget impact analysis II - applications & design issues. Brodtkorb TH, Brogan AJEarnshaw SR

1:00-5:00 

 

Stated preference methods - part II.  Bridges JFP, Hauber AB, Marshall D. 

Monday, May 20 - ISPOR Scientific Session Contributions 

10:30-2:00 

Session I

10:30-2:00 

Session I 

12:30-1:30 

Educational Symposium 

12:30-1:45 

Forum

2:30-3:00 

HEOR Theater 

2:15-3:15 

Spotlight Session 

Back to the future in Value in Health (SP2). Drummond M, Hay J, Mauskopf J, Mullins CD. 

3:45-4:45 

Breakout Session  

Proactive - linking design, analysis and interpretation of PROs in clinical trials. (W4) Manson S, Mishra-Kalyani P, Roydhouse J, Stull D

3:30-7:00 

Session II 

Exploring variability in patient-reported pain and treatment efficacy in patients with endometriosis. (PIH70) Houghton K, Ainsworth C, Stull D, Haberland C, Filonenko A, Seitz C, Gerlinger C. 

3:30-7:00 

Session II 

3:30-7:00 

Session II 

Economic burden of unintended pregnancy in the United States. (PIH36) Filonenka A, Law A, Purser M, Mader G, Graham J. 

3:30-7:00 

Session II 

Gabriel A, Apostolides J, Nickodem A, Rad AN, Patel V, Zaw R, Martin S, Harris N, Jones G, Nahabedian MY. 

Tuesday, May 21 - ISPOR Scientific Session Contributions 

10:30-2:00 

Session III 

Impact of healthcare utilization on meningococcal adolescent vaccination in the United States (US). (PIN74) Esterberg E, Kurosky SK, Trantham L, Irwin D, Packnett E, Novy PWhelan J, Hogea C. 

10:30-2:00 

Session III 

10:30-2:00 

Session III 

Budget-impact and cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis from a US health plan perspective. (PBI30) Carrico JJia X, Zhao Y, Zhang J, Brodtkorb TH, Mendelsohn AB, Lowry S, Wu JJ, Feldman SR, Armstrong AW 

10:30-2:00 Session III Vaccination and potential missed opportunities among adults in the United States during the Affordable Care Act era. (PIN71) Aris E, Montourcy M, Esterberg E, Kurosky SK, Poston S, Hogea C. 

10:30-2:00 

Session III 

12:30-1:45

Forum

ISPOR Personalized Precision Medicine Special Interest Group - Leveraging real world evidence to address uncertainty for transformative and curative therapiesModerator: Purser M. Panelists: Faulkner E, Paramore C, Daniel G. 

3:30-7:00 

Session IV 

Cost-benefit analysis of vaccination against four preventable diseases in older adults in the United States(PMU14) Talbird S, La E, Carrico J, Poston S, Poirrier JE, DeMartino JK, Hogea C. 

3:30-7:00 

Session IV 

3:30-7:00 

Session IV 

Improved quality of life and life-years in patients with infantile-onset SMA following treatment with nusinersen. (PRO14) Zuluaga Sanchez S, Purser M, Mader G, Gould IG, Knight C, Johnson NB, Patel MJensen J, Odom T. 

3:30-7:00 

Session IV 

3:30-7:00 

Session IV 

3:30-7:00 

Session IV 

Autoimmune disorders among adults with asthma: an economic outlook. (PRS15) Ajmera M, Parikh R, Meyers J. 

3:30-7:00 

Session IV 

Improved quality of life for patients and caregivers among patients with later-onset SMA following treatment with nusinersen. (PRO16) Zuluaga Sanchez S, Purser M, Mader G, Gould IG, Knight C, Johnson NB, Patel M, Jensen J, Odom T.

 

3:30-7:00 

Session IV 

Wednesday, May 22 - ISPOR Scientific Session Contributions 

9:30-2:00 

Session V 

9:30-2:00 

Session V 

9:30-2:00 

Session V 

9:30-2:00 

Session V 

9:30-2:00 

Session V